Investigator Site 1034 — Duluth, Minnesota

Investigator Site 1034 is a clinical research site located in Duluth, Minnesota, United States 55807.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 1034 has participated in 1 clinical trials.

Therapeutic areas: Acute Coronary Syndrome.

Sponsors: Anthera Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Duluth

Browse all research sites in Minnesota · View every site in Duluth

• University of Minnesota Duluth
• St Lukes Hospital
• St. Luke's Hospital and Clinics
• Saint Lukes Hospital
• Saint Luke's Hospital of Duluth
• Essentia Institute for Rural Health / St Mary's Hospital
• St. Luke's Hospital and Health Network
• St. Luke's Hospital Association of Duluth
• St. Luke's Hospital Cancer Care Center
• St. Luke's University Hospital /ID# 171374
• St. Luke's Hospital of Duluth
• St. Lukes Hospital of Duluth /ID# 250021

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 1034?

Investigator Site 1034 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 1034 conducted?

Investigator Site 1034 has 1 clinical trials on record. Their work covers Acute Coronary Syndrome.

Is Investigator Site 1034 accredited by Crixeo Clinical Trials?

Investigator Site 1034 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 1034?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.